Nucleic acid delivery with ovine adenoviral vectors
US6020172A · kind A · utility
12Cited by
0References
51Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 20, 1998 |
| Grant date | Feb 1, 2000 |
| Priority date | — |
| Expiry date | Apr 20, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/008
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of delivering a nucleic acid molecule to a human cell which involves exposing to the cell a viral vector containing a DNA molecule including a nucleic acid sequence encoding the genome of an ovine adenovirus capable of infecting human cells or functionally equivalent nucleic acid sequence or portion thereof and at least one nucleic acid sequence encoding a gene to be expressed in the cell, such that the vector infects the cell and the infected cell expresses the gene.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.